JLA MEDIA LTD
Company number 06606378 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Score: B-
Explanation: JLA Media Ltd is not in the emergency room, but it is exhibiting symptoms of a chronic condition. The company benefits from a strong "immune system" in the form of substantial cash reserves, which fends off immediate insolvency. However, it is experiencing significant "atrophy" (shrinking size) and "anemia" (loss of profitability), with the asset base and cash reserves declining steadily over recent years. The high reliance on creditor financing also suggests a highly leveraged, thin-equity structure that could be vulnerable to shocks.
Key Vital Signs
1. Blood Pressure (Liquidity & Current Ratio) * Metric: Current Assets (£582,513) vs. Current Liabilities (£469,053) * Reading: Current Ratio of 1.24:1 * Interpretation: The company's blood pressure is stable but slightly low. A current ratio of 1.24 means the business has £1.24 of assets due within a year for every £1 of short-term debts. This is sufficient to keep the circulation going, but it leaves little margin for error if trade debtors fail to pay on time.
2. Blood Sugar (Cash Reserves) * Metric: Cash at bank fell from £576,580 (2023) to £415,021 (2024) * Reading: High absolute levels, but dropping rapidly (a 28% decrease year-on-year). * Interpretation: The patient has good energy reserves currently, but the sugar levels are depleting fast. Over the last two years, cash has fallen from a peak of £760,308 (2022) to £415,021. This hemorrhage of cash needs to be stabilized before reserves reach critical levels.
3. Cholesterol (Liabilities & Debt) * Metric: Total Liabilities of £469,053 against Shareholders' Equity of £116,468 * Reading: Debt-to-Equity ratio of approximately 4.0:1 * Interpretation: The company has high "bad cholesterol." For every £1 of the owners' equity, there is £4 of liability. While a large portion of this is trade creditors and tax (normal operating expenses), the heavy reliance on external financing rather than internal equity makes the business structurally vulnerable.
4. Muscle Mass (Net Assets / Equity) * Metric: Net Assets dropped from £123,963 (2023) to £116,468 (2024) * Reading: Thin and declining. * Interpretation: The business has very little skin in the game. With total equity of just £116k supporting a business with nearly £600k in assets, the structural foundation is fragile.
Diagnosis
1. Business Atrophy (Shrinking Scale) The patient is losing weight, and not in a healthy way. Total assets have shrunk from £894,474 in 2022 to £582,513 in 2024. Trade debtors have also decreased from £180,911 to £142,436. While lower debtors might mean better collection, combined with shrinking assets, it strongly suggests a contraction in revenue and overall business activity. The agency is doing less business than it was two years ago.
2. Profitability Anemia The Profit and Loss reserve dropped from £123,863 in 2023 to £116,368 in 2024, indicating a loss of £7,495 for the year. The business is not generating enough nutritional intake (profit) to sustain itself. In a business with £582k in assets, generating a net loss is a symptom of either shrinking margins or unacceptable overhead costs relative to revenue.
3. Detoxification (Debt Reduction) There is a positive health signal here: the business is actively clearing out toxins. Total liabilities have been reduced from £795,818 in 2022 to £469,053 in 2024. Specifically, "Other Creditors" (which includes director loans) dropped from £492,324 to £325,070, and the accounts confirm that director loans were reduced by £132,500. The directors are successfully paying down internal debt, but this detox is currently draining the cash reserves faster than the business can replenish them through operations.
Prognosis
The short-term prognosis is stable but guarded. The company is not at immediate risk of cardiac arrest (insolvency) because it still holds over £415,000 in cash. However, if the current trajectory continues—operating losses combined with cash drain to repay directors—the business will face serious financial distress within 2-3 years. The company must return to profitability and stop relying on its historic cash reserves to fund debt repayments and operating losses.
Recommendations
- Stabilize the Cash Hemorrhage: Immediately review cash outflows. While paying down the director loans is commendable, doing so at the expense of working capital while the business is making a loss is dangerous. Consider slowing down director loan repayments until the business returns to positive cash generation.
- Nutritional Intake (Revenue Recovery): The shrinking asset base and debtors suggest a drop in revenue. Management must focus on top-line growth—acquiring new clients and increasing billings—to reverse the atrophy.
- Metabolic Efficiency (Cost Control): With 9 employees and a net loss, the business must assess whether its current staffing and overhead levels are sustainable for the current level of revenue. Trim the fat without cutting into the muscle.
- Monitor Trade Debtors: With £142,436 outstanding in trade debtors, ensure that credit control is rigorous. Late payments from clients will quickly turn the current ratio of 1.24 into a liquidity crisis.